Ethiodized Oil
Hepatic Portal Vein Tumor Invasion
Third Affiliated Hospital, Sun Yat-Sen UniversityPhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Hepatic Portal Vein Tumor Invasion cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Epirubicin RenJi Hospital | Phase 3 | B |
Inno-206 Shanghai Zhongshan Hospital | Phase 3 | B |
Theprubicin Third Affiliated Hospital, Sun Yat-Sen University | Phase 3 | B |
Atezolizumab Third Affiliated Hospital, Sun Yat-Sen University | Phase 2 | CCC |
Same molecule, other indications
Ethiodized Oil is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →